4.14 USD
-0.05 (-1.19%)
4.13 USD
-0.01 (-0.24%)
ChartMill assigns a Buy % Consensus number of 78% to ADVM. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 10.1. This target is 143.91% above the current price.
ADVM was analyzed by 12 analysts. The buy percentage consensus is at 78. So analysts seem to be have mildly positive about ADVM.
In the previous month the buy percentage consensus was at a similar level.
ADVM was analyzed by 12 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-11-17 | HC Wainwright & Co. | Downgrade | Buy -> Neutral |
| 2025-10-28 | RBC Capital | Maintains | Sector Perform -> Sector Perform |
| 2025-09-23 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-08-13 | Chardan Capital | Maintains | Buy -> Buy |
| 2025-06-26 | Mizuho | Maintains | Outperform -> Outperform |
| 2025-05-15 | Chardan Capital | Maintains | Buy -> Buy |
| 2025-05-15 | RBC Capital | Maintains | Sector Perform -> Sector Perform |
| 2025-05-15 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-04-17 | Chardan Capital | Maintains | Buy -> Buy |
| 2025-04-16 | RBC Capital | Maintains | Sector Perform -> Sector Perform |
| 2025-04-16 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-11-19 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-11-05 | RBC Capital | Maintains | Sector Perform -> Sector Perform |
| 2024-08-14 | Truist Securities | Maintains | Buy -> Buy |
| 2024-08-13 | RBC Capital | Maintains | Sector Perform -> Sector Perform |
| 2024-08-13 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-07-18 | Chardan Capital | Maintains | Buy -> Buy |
| 2024-06-25 | Oppenheimer | Initiate | Outperform |
| 2024-05-15 | Truist Securities | Maintains | Buy -> Buy |
| 2024-05-10 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-04-30 | HC Wainwright & Co. | Initiate | Buy |
| 2024-04-29 | Mizuho | Maintains | Buy -> Buy |
| 2024-03-19 | Chardan Capital | Reiterate | Buy -> Buy |
| 2024-03-19 | RBC Capital | Maintains | Sector Perform -> Sector Perform |
| 2024-02-06 | Mizuho | Maintains | Buy -> Buy |
| 2023-11-02 | Mizuho | Initiate | Buy |
| 2023-09-05 | Truist Securities | Reiterate | Buy -> Buy |
| 2023-08-11 | Chardan Capital | Upgrade | Neutral -> Buy |
| 2023-03-07 | Ladenburg Thalmann | Initiate | Buy |
| 2022-11-11 | Chardan Capital | Maintains | Neutral |
ADVERUM BIOTECHNOLOGIES INC / ADVM FAQ
What is the price target for ADVM stock?
12 analysts have analysed ADVM and the average price target is 10.1 USD. This implies a price increase of 143.91% is expected in the next year compared to the current price of 4.14.
What is the consensus rating for ADVM stock?
The consensus rating for ADVERUM BIOTECHNOLOGIES INC (ADVM) is 78.3333 / 100 . This indicates that analysts generally have a positive outlook on the stock.
What is the number of analysts for ADVM stock?
The number of analysts covering ADVERUM BIOTECHNOLOGIES INC (ADVM) is 12.